Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
Tunheim G, Arnemo M, Næss LM, Fjeldheim ÅK, Nome L, Bolstad K, Aase A, Mandiarote A, González H, González D, García L, Cardoso D, Norheim G, Rosenqvist E. Tunheim G, et al. Among authors: gonzalez d, gonzalez h. Vaccine. 2013 Dec 9;31(51):6097-106. doi: 10.1016/j.vaccine.2013.09.044. Epub 2013 Oct 10. Vaccine. 2013. PMID: 24120679
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
Acevedo R, Zayas C, Norheim G, Fernández S, Cedré B, Aranguren Y, Cuello M, Rodriguez Y, González H, Mandiarote A, Pérez M, Hernández M, Hernández-Cedeño M, González D, Brorson SH, Rosenqvist E, Naess L, Tunheim G, Cardoso D, García L. Acevedo R, et al. Among authors: gonzalez d, gonzalez h. Pharmacol Res. 2017 Jul;121:194-201. doi: 10.1016/j.phrs.2017.04.030. Epub 2017 May 8. Pharmacol Res. 2017. PMID: 28495657
Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults.
Valera R, García HM, Jidy MD, Mirabal M, Armesto MI, Fando R, García L, Fernández R, Año G, Cedré B, Ramírez M, Bravo L, Serrano T, Palma S, González D, Miralles F, Medina V, Nuñez F, Plasencia Y, Martínez JC, Mandarioti A, Lugones J, Rodríguez BL, Moreno A, González D, Baro M, Solis RL, Sierra G, Barbera R, Domínguez F, Gutiérrez C, Kouri G, Campa C, Menéndez J. Valera R, et al. Among authors: gonzalez d. Vaccine. 2009 Nov 5;27(47):6564-9. doi: 10.1016/j.vaccine.2009.08.042. Epub 2009 Aug 29. Vaccine. 2009. PMID: 19720365 Clinical Trial.
Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine.
Pérez O, Bracho G, Lastre M, Zayas C, González D, Gil D, del Campo J, Acevedo R, Taboada C, Rodríguez T, Fajardo ME, Sierra G, Campa C, Mora N, Barberá R, Solís RL. Pérez O, et al. Among authors: gonzalez d. Vaccine. 2006 Apr 12;24 Suppl 2:S2-52-3. doi: 10.1016/j.vaccine.2005.01.127. Vaccine. 2006. PMID: 16823925
Scale up of proteoliposome derived Cochleate production.
Zayas C, Bracho G, Lastre M, González D, Gil D, Acevedo R, del Campo J, Taboada C, Solís RL, Barberá R, Pérez O. Zayas C, et al. Among authors: gonzalez d. Vaccine. 2006 Apr 12;24 Suppl 2:S2-94-5. doi: 10.1016/j.vaccine.2005.01.139. Vaccine. 2006. PMID: 16823944
Proteoliposome derived cochleate as novel adjuvant.
Bracho G, Lastre M, del Campo J, Zayas C, González D, Gil D, Acevedo R, Taboada C, Solís RL, Pérez O. Bracho G, et al. Among authors: gonzalez d. Vaccine. 2006 Apr 12;24 Suppl 2:S2-30-1. doi: 10.1016/j.vaccine.2005.01.108. Vaccine. 2006. PMID: 16823914
New vaccines require potent adjuvants like AFPL1 and AFCo1.
Pérez O, Lastre M, Cabrera O, del Campo J, Bracho G, Cuello M, Balboa J, Acevedo R, Zayas C, Gil D, Mora N, González D, Pérez R, González E, Barberá R, Fajardo EM, Sierra G, Solís RL, Campa C. Pérez O, et al. Among authors: gonzalez e, gonzalez d. Scand J Immunol. 2007 Aug-Sep;66(2-3):271-7. doi: 10.1111/j.1365-3083.2007.01981.x. Scand J Immunol. 2007. PMID: 17635804 Free article.
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.
Zayas C, González D, Acevedo R, del Campo J, Lastre M, González E, Romeu B, Cuello M, Balboa J, Cabrera O, Guilherme L, Pérez O. Zayas C, et al. Among authors: gonzalez e, gonzalez d. BMC Immunol. 2013;14 Suppl 1(Suppl 1):S4. doi: 10.1186/1471-2172-14-S1-S4. Epub 2013 Feb 25. BMC Immunol. 2013. PMID: 23458578 Free PMC article.
Quantitative proton nuclear magnetic resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X.
Garrido R, Puyada A, Fernández A, González M, Ramírez U, Cardoso F, Valdés Y, González D, Fernández V, Vérez V, Vélez H. Garrido R, et al. Among authors: gonzalez d, gonzalez m. J Pharm Biomed Anal. 2012 Nov;70:295-300. doi: 10.1016/j.jpba.2012.07.014. Epub 2012 Jul 22. J Pharm Biomed Anal. 2012. PMID: 22877873
2,188 results